Riskpilot← Back to searchSign inGet full accessAeriant Therapeutics AB
ABActiveOrg 5566835244Stortorget 1 2 TrEngineering activities and related technical consultancy · NACE 7112Est. 20050 employees
Revenue 2024
SEK 0
EBITDA margin
—
-60% vs 2023
Equity ratio
92.8%
Financial strength
Net profit 2024
SEK -16K
-60% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -16K | -60% |
| Net profit | SEK -16K | -60% |
| Total assets | SEK 935K | -2% |
| Equity | SEK 868K | -2% |
| Employees | 0 | — |
Legal name
Aeriant Therapeutics AB
Org number
5566835244
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
11 juli 2005
Share capital
SEK 133 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets verksamhet skall vara att tillverka, utveckla, idka handel med medicinska-, diagnostiska-, farmaceutiska- och kemisk- tekniska produkter, förvärva och upplåta licenser och agenturer för sådana produkter samt därmed förenlig verksamhet. Bolaget ska även idka finansiell verksamhet, dock inte sådan verksamhet som avses i bankrörelselagen eller lagen om kreditmarknadsbolag.
Address
Stortorget 1 2 Tr
Email
christer.fahraeus@eqlpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −18 | −5 | −13 | −10 | −16 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −18 | −5 | −13 | −10 | −16 |
| Net financials | — | — | — | — | — |
| Profit before tax | −18 | −5 | 727 | −10 | −16 |
| Tax | −0 | −0 | −1 | −0 | −0 |
| Net profit | −18 | −5 | 726 | −10 | −16 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 253 | 237 | 964 | 952 | 935 |
| Equity | 173 | 168 | 894 | 884 | 868 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 80 | 70 | 71 | 68 | 67 |
| Total debt | 80 | 70 | 71 | 68 | 67 |
EBITDA margin
-1600000.0%
This company
15.8%
Market median
-10126682% vs market
20202024
Equity ratio
92.8%
This company
38.2%
Market median
+143% vs market
20202024
Return on equity
-1.8%
This company
18.4%
Market median
-110% vs market
20202024
Net profit margin
-1600000.0%
This company
8.1%
Market median
-19753186% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CN Chief Executive Officer | Chief Executive Officer | 2025 |
CO Audit | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Deputy Board Member | 2025 | |
| Former (3) | ||
| Deputy Board Member | 2023 – 2025 | |
| Deputy Board Member | 2020 – 2023 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aeriant Therapeutics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christoph Nowak | Chief Executive Officer | 0 companies |
| Carl Olov Strömberg | Audit | 0 companies |
| Nils Emanuel Stihl | Deputy Board Member | 0 companies |
| Lars Christer Fredrik Fåhraeus | Chairman | 0 companies |
| Ebba Cecilia Margareta Fåhraeus | Deputy Board Member | 0 companies |
| Mark Ernest Kornfeld | Board of Directors | 0 companies |
| Tom Wilkinson | Board of Directors | 0 companies |
| Per Fredrik Lehmann | Board of Directors | 0 companies |
| Nils Olof Wranne | Board of Directors | 0 companies |
| Carl Simon Lars Fåhraeus Gränse | Deputy Board Member | 0 companies |